New drugs in respiratory disorders: II.
D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D000658:Amoxicillin / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D002511:Cephalosporins / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D002511:Cephalosporins; D004338:Drug Combinations; D008795:Metronidazole; D011718:Pyrazinamide; D004917:Erythromycin; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D004977:Ethambutol; D003520:Cyclophosphamide; D014295:Trimethoprim; D000547:Amantadine; D012293:Rifampin